Skip to content
AwardedPRTGoodsFramework agreement€298,033

2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS]

Published
Published 9 June 2026

Overview

Unidade Local de Saúde Santa Maria procured Emicizumab 150 mg/ml 0.4 ml solution for injection in vials, a pharmaceutical product valued at 298,033.05 EUR. The contract was awarded to ROCHE Farmacêutica Química, LDA on 31 March 2026 and is now complete.

Key details

Country
PRT
Status
Awarded
Category
Goods
Estimated value
€298,033
Procedure
Selective
Contract type
Framework agreement
Published
9 June 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
€298,033
Award date
31 March 2026
Contract period
— → 26 December 2026
Winner
  • ROCHE Farmacêutica Química, LDA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 June 2026

Contracting authority

  • Unidade Local de Saúde Santa Maria, E.P.E.

    Procuring entity

    Lisboa, PRT

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 2025/1746 -EMICIZUMAB [150 MG/ML 0,4 ML SOL INJ FRS] — won by ROCHE Farmacêutica Química, LDA — Skim